Table 4.
Substance | Reference | External dose (mg/kg body weight/d) | Modeled TWA (mg/mL) | Concentration at end of the study (mg/mL) | ||
---|---|---|---|---|---|---|
Modeled | Reported mean | Ratio | ||||
PFBS | Lieder et al.86 | 30 | 0.016 | 0.0018 | — | — |
100 | 0.053 | 0.0059 | — | — | ||
300 | 0.16 | 0.018 | — | — | ||
1,000 | 3.7 | 0.059 | — | — | ||
PFHxS | Butenhoff et al.87 | 0.3 | 0.024 | 0.042 | 0.044 | 1.0 |
1 | 0.080 | 0.14 | 0.089 | 1.6 | ||
3 | 0.24 | 0.42 | 0.13 | 3.2 | ||
10 | 0.80 | 1.4 | 0.20 | 7.0 | ||
PFOS | Seacat et al.88 | 0.03 | 0.0015 | 0.0025 | 0.0040 | 0.6 |
0.13 | 0.0065 | 0.011 | 0.017 | 0.6 | ||
0.34 | 0.017 | 0.029 | 0.044 | 0.7 | ||
1.33 | 0.066 | 0.11 | 0.15 | 0.7 | ||
PFBA | Butenhoff et al.89 | 1.2 | 0.0028 | 0.0012 | 0.0061 | 0.2 |
6 | 0.014 | 0.0061 | 0.014 | 0.4 | ||
30 | 0.071 | 0.030 | 0.052 | 0.6 | ||
PFHxA | Loveless et al.90 | 20 | 0.0017 | 0.00032 | — | — |
100 | 0.0083 | 0.0016 | — | — | ||
500 | 0.041 | 0.0081 | — | — | ||
PFOA | Perkins et al.91 | 0.06 | 0.0047 | 0.0059 | 0.0071 | 0.8 |
0.64 | 0.050 | 0.062 | 0.041 | 1.5 | ||
1.94 | 0.15 | 0.19 | 0.070 | 2.7 | ||
6.5 | 0.51 | 0.63 | 0.14 | 4.5 | ||
PFNA | Mertens et al.92 | 0.025 | 0.0044 | 0.010 | — | — |
0.125 | 0.022 | 0.051 | — | — | ||
0.6 | 0.11 | 0.25 | — | — | ||
PFDoDA | Kato et al.93 | 0.1 | 0.0019 | 0.0049 | — | — |
0.5 | 0.0096 | 0.024 | — | — | ||
2.5 | 0.048 | 0.12 | — | — | ||
HFPO-DA | Haas94 | 0.1 | 0.000051 | 0.000069 | — | — |
10 | 0.0051 | 0.00069 | — | — | ||
100 | 0.051 | 0.0069 | — | — |
Note: —, no data; HFPO-DA, hexafluoropropylene oxide-dimer acid; PFBA, perfluorobutanoic acid; PFBS, perfluorobutane sulfonic acid; PFDoDA, perfluorododecanoic acid; PFHxA, perfluorohexanoic acid; PFHxS, perfluorohexane sulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonic acid.